Shanghai ZJ Bio-Tech , Ltd. Common Stock

The latest common stock for 688317.SS is $190M as of June 2026. That compares with $190M in the prior-year period — up 0.0% year over year. Investors often review this figure alongside Shanghai ZJ Bio-Tech , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 688317.SS's common stock moved from $190M to $190M — essentially flat versus a year earlier. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Shanghai ZJ Bio-Tech , Ltd.'s operating scale or balance-sheet position.

A common stock figure of $190M for 688317.SS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 688317.SS's common stock ($190M), review year-over-year change from $190M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Shanghai ZJ Bio-Tech , Ltd.'s common stock against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.